CARsgen Therapeutics (HKG:2171) released 2,667,000 options to 31 grantees under its post-initial public offering share option scheme, according to a Tuesday filing with the Hong Kong Exchange.
The options represent 2,667,000 shares with an exercise price of HK$7.26 per share, the filing said.
Director Hua Jiang will receive 200,000 options while the rest of the employees will get an aggregate of 2,467,000 options, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.